Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100

Quest Diagnostics Incorporated (DGX) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/FCF of 23.1×. Over the past ten years it has ranged from 9.2× (June 2021) to 33.4× (December 2023); the current reading is higher than 83% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 18.0× (26.85%)
FY2024 24.7× 7.60%
FY2023 22.9× 38.54%
FY2022 16.5× 22.22%
FY2021 13.5× 14.09%
FY2020 11.9× (44.10%)
FY2019 21.2× 14.94%
FY2018 18.5× (0.91%)
FY2017 18.6× (6.04%)
FY2016 19.8× (19.61%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 21.2× 4.60%
Mar 2026 20.2× 12.15%
Dec 2025 18.0× (5.50%)
Sep 2025 19.1× (8.28%)
42 more quarters

Against its own ten years

Low 9.2× High 33.4×
Ten-year median 20.7×
Current reading's percentile 85

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on DGX